drugset / Trial / NCT00518960
The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic Syndrome
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the effectiveness of ProAlgaZyme in increasing levels of HDL 'good' cholesterol and decreasing total cholesterol and C-reactive protein in patients with Metabolic Syndrome.
Timeline
- Start
- 2007-04
- Primary completion
- —
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ProAlgaZyme | Other / unclassified | — | — |